Abstract
This theoretical study seeks to critically review the use of excipients in the paediatric population. This study is based on the rules and recommendations of European and American drug regulatory agencies. On the one hand, this review describes the most frequent excipients used in paediatric medicine formulations, identifying the compounds that scientific literature has marked as potentially harmful regarding the side effects generated after exposure. On the other hand, this review also highlights the importance of carrying out safety -checks on the excipients, which, in most cases, are linked to toxicity studies. An excipient in the compilation of paediatric population databases is expected to target safety and toxicity, as in the STEP database. Finally, a promising pharmaceutical form for child population, ODT (Orally Disintegrating Tablets), will be studied.
Reference132 articles.
1. Formulación magistral y excipientes en pediatría. El Farma-céutico;Cañete;Hospitales,2018
2. The STEP (Safety and Toxicity of Excipients for Paediatrics) database: Part 2 – The pilot version
3. Safety of Excipients in Pediatric Formulations—A Call for Toxicity Studies in Juvenile Animals?
4. Guideline on Pharmaceutical Development of Medicines for Paediatric Usehttps://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmaceutical-development-medicines-paediatric-use_en.pdf
5. The European Regulation on medicines for paediatric use
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献